[1]JournalofMedicinalChemistry,2004,vol.47,p.1602-1604
[1]Patent:WO2006/133098,2006,A2.Locationinpatent:Page/Pagecolumn46-47;6/18
[1]BiochimicaetBiophysicaActa-GeneralSubjects,2019,vol.1863,p.577-585
5078-07-9 | 2-Methylbenzo[d]oxazol-6-ol | AA00DCXY | MFCD00464862
519016-86-5 | 2-Amino-4-(3,4-dimethylphenyl)thiophene-3-carboxamide | AA00DD1H | MFCD02609525
54439-75-7 | 2-Chloro-4-methoxybenzaldehyde | AA00DD5M | MFCD01741722
5511-98-8 | ALPHA-ACETYLDIGOXIN | AA00DDAW | MFCD00135692
504413-26-7 | 2,2,2-Trifluoro-n-(imidazo[1,2-a]pyridin-2-yl)acetamide | AA00DDH0 | MFCD13177130
5380-87-0 | Furfuryl glycidyl ether | AA00DDPH | MFCD00013348
4959-60-8 | 4,5-Dimethoxy-2-nitrobenzamide | AA00DDV7 | MFCD00171550
45889-43-8 | 1-(2-Hydroxyethyl)-eta-caprolactam | AA00DE14 | MFCD12186723
51264-78-9 | 2-(4-Formylphenoxy)propanoic acid | AA00DE7R | MFCD03850823
500024-85-1 | N-Hydroxy-1H-pyrrole-2-carboximidamide | AA00DEF1 | MFCD09751584